Lapatinib is an organofluorine compound, an organochlorine compound, a member of quinazolines and a member of furans. Among its listed roles, it functions as a antineoplastic agent and a tyrosine kinase inhibitor. Functionally, it is related to monofluorobenzene. It is grouped under the following drug class(es): Kinase inhibitors, QTc-prolonging agents and Tyrosine Kinase Inhibitors. Its therapeutic use is listed as anti-cancer agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Lapatinibum and Tykerb. Its PubChem CID is 208908.
Lapatinib
| CAS No | 231277-92-2 |
|---|---|
| Molecular Formula | C29H26ClFN4O4S |
| Molecular Weight | 581.11 g/mol |
| Synonyms | N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Lapatinib is an organofluorine compound, an organochlorine compound, a member of quinazolines and a member of furans. Among its listed roles, it functions as a antineoplastic agent and a tyrosine kinase inhibitor.
The listed CAS number is 231277-92-2.
The listed molecular formula is C29H26ClFN4O4S.
The listed molecular weight is 581.11 g/mol.
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine.
The source lists Lapatinibum and Tykerb.